CN102416179B - 用于哮喘的吸入性复方组合物 - Google Patents
用于哮喘的吸入性复方组合物 Download PDFInfo
- Publication number
- CN102416179B CN102416179B CN201010502339.3A CN201010502339A CN102416179B CN 102416179 B CN102416179 B CN 102416179B CN 201010502339 A CN201010502339 A CN 201010502339A CN 102416179 B CN102416179 B CN 102416179B
- Authority
- CN
- China
- Prior art keywords
- budesonide
- procaterol
- beta
- asthma
- collocation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
- A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/138—Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4704—2-Quinolinones, e.g. carbostyril
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
Abstract
Description
Claims (4)
Priority Applications (11)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201010502339.3A CN102416179B (zh) | 2010-09-28 | 2010-09-28 | 用于哮喘的吸入性复方组合物 |
KR1020137010636A KR101475262B1 (ko) | 2010-09-28 | 2011-02-01 | 천식 치료에 사용되는 흡입용 복합 조성물 |
SG2013016621A SG188426A1 (en) | 2010-09-28 | 2011-02-01 | Compound composition for inhalation used for treating asthma |
MYPI2013000680A MY179794A (en) | 2010-09-28 | 2011-02-01 | Compound composition for inhalation used for treating asthma |
US13/876,387 US8877740B2 (en) | 2010-09-28 | 2011-02-01 | Compound composition for inhalation used for treating asthma |
AU2011307899A AU2011307899B2 (en) | 2010-09-28 | 2011-02-01 | Compound composition for inhalation used for treating asthma |
EP11827927.2A EP2626065A4 (en) | 2010-09-28 | 2011-02-01 | INHIBITABLE COMPOSITION COMPOSITION FOR THE TREATMENT OF ASTHMA |
NZ607900A NZ607900A (en) | 2010-09-28 | 2011-02-01 | Compound composition for inhalation used for treating asthma |
PCT/CN2011/070883 WO2012041031A1 (zh) | 2010-09-28 | 2011-02-01 | 一种用于哮喘的吸入性复方组合物 |
CA2811345A CA2811345C (en) | 2010-09-28 | 2011-02-01 | Compound composition for inhalation used for treating asthma |
HK12110225.2A HK1169334A1 (zh) | 2010-09-28 | 2012-10-16 | 用於哮喘的吸入性複方組合物 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201010502339.3A CN102416179B (zh) | 2010-09-28 | 2010-09-28 | 用于哮喘的吸入性复方组合物 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN102416179A CN102416179A (zh) | 2012-04-18 |
CN102416179B true CN102416179B (zh) | 2014-05-07 |
Family
ID=45891864
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201010502339.3A Active CN102416179B (zh) | 2010-09-28 | 2010-09-28 | 用于哮喘的吸入性复方组合物 |
Country Status (11)
Country | Link |
---|---|
US (1) | US8877740B2 (zh) |
EP (1) | EP2626065A4 (zh) |
KR (1) | KR101475262B1 (zh) |
CN (1) | CN102416179B (zh) |
AU (1) | AU2011307899B2 (zh) |
CA (1) | CA2811345C (zh) |
HK (1) | HK1169334A1 (zh) |
MY (1) | MY179794A (zh) |
NZ (1) | NZ607900A (zh) |
SG (1) | SG188426A1 (zh) |
WO (1) | WO2012041031A1 (zh) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR970020116A (ko) * | 1995-09-19 | 1997-05-28 | 노보루 아까사까 | 인간 뇨 트립신 억제제 제제 및 그의 제조방법 |
TWI399202B (zh) * | 2011-03-17 | 2013-06-21 | Intech Biopharm Ltd | 製備用於治療呼吸道疾病之定量噴霧吸入劑的製程方法 |
CN104069497A (zh) * | 2014-06-27 | 2014-10-01 | 东莞市凯法生物医药有限公司 | 一种降低药物耐受性的组合物、方法及其应用 |
GB2545025A (en) * | 2015-12-04 | 2017-06-07 | Mexichem Fluor Sa De Cv | Pharmaceutical composition |
CN110025578B (zh) * | 2019-04-10 | 2021-06-15 | 深圳市新阳唯康科技有限公司 | 一种治疗哮喘类肺部疾病的共无定形粉末及其制备方法 |
CN115463117A (zh) * | 2022-09-14 | 2022-12-13 | 四川普锐特药业有限公司 | 一种递送效率高的布地奈德沙丁胺醇复方雾化吸入混悬液及其制备方法 |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1298699A (zh) * | 2000-02-15 | 2001-06-13 | 丛繁滋 | 速效平喘气雾剂及其制备方法 |
CN1305380A (zh) * | 1998-06-11 | 2001-07-25 | 阿斯特拉曾尼卡有限公司 | 含有福莫特罗和布地奈德的组合物在预防和治疗急性气喘疾病中的应用 |
CN1353980A (zh) * | 2001-11-14 | 2002-06-19 | 丛繁滋 | 速效平喘气雾剂及其制备方法 |
Family Cites Families (46)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5270305A (en) | 1989-09-08 | 1993-12-14 | Glaxo Group Limited | Medicaments |
US6123924A (en) | 1991-09-25 | 2000-09-26 | Fisons Plc | Pressurized aerosol inhalation compositions |
NZ244439A (en) | 1991-09-25 | 1994-01-26 | Fisons Plc | Pressurised aerosol compositions comprising hydrofluoroalkane, dispersed |
US5658549A (en) | 1991-12-12 | 1997-08-19 | Glaxo Group Limited | Aerosol formulations containing propellant 134a and fluticasone propionate |
IL104068A (en) | 1991-12-12 | 1998-10-30 | Glaxo Group Ltd | Pharmaceutical preparations in a spray without surfactant containing 1, 1, 1, 2 tetrafluoroethane or 1,1,2,3,3 petafluor N propane as propellant |
AU673660C (en) | 1991-12-18 | 2002-07-25 | Astrazeneca Ab | New combination of formoterol and budesonide |
CN1088580C (zh) * | 1994-12-22 | 2002-08-07 | 阿斯特拉公司 | 气溶胶药物制剂 |
WO1996032150A1 (en) | 1995-04-14 | 1996-10-17 | Glaxo Wellcome Inc. | Metered dose inhaler for salmeterol |
EP1166811B1 (en) | 1995-04-14 | 2006-12-06 | SmithKline Beecham Corporation | Metered dose inhaler for fluticasone propionate |
GB9626960D0 (en) | 1996-12-27 | 1997-02-12 | Glaxo Group Ltd | Valve for aerosol container |
US6503537B2 (en) | 1997-03-20 | 2003-01-07 | Schering Corporation | Preparation of powder agglomerates |
US6309623B1 (en) | 1997-09-29 | 2001-10-30 | Inhale Therapeutic Systems, Inc. | Stabilized preparations for use in metered dose inhalers |
GB9807232D0 (en) | 1998-04-03 | 1998-06-03 | Univ Cardiff | Aerosol composition |
GB9904919D0 (en) | 1999-03-03 | 1999-04-28 | Novartis Ag | Organic compounds |
US6962151B1 (en) | 1999-11-05 | 2005-11-08 | Pari GmbH Spezialisten für effektive Inhalation | Inhalation nebulizer |
US6596261B1 (en) | 2000-01-25 | 2003-07-22 | Aeropharm Technology Incorporated | Method of administering a medicinal aerosol formulation |
FI20002216A0 (fi) | 2000-10-06 | 2000-10-06 | Orion Yhtymae Oyj | Yhdistelmäpartikkelit astman hoitoon |
FI20002215A0 (fi) | 2000-10-06 | 2000-10-06 | Orion Yhtymae Oyj | Yhdistelmäpartikkelit |
US6799572B2 (en) | 2000-12-22 | 2004-10-05 | Chrysalis Technologies Incorporated | Disposable aerosol generator system and methods for administering the aerosol |
CZ301676B6 (cs) | 2001-03-30 | 2010-05-19 | Jagotec Ag | Farmaceutický suspenzní aerosolový prípravek pro inhalaci a použití soli karboxylové kyseliny |
US6667344B2 (en) | 2001-04-17 | 2003-12-23 | Dey, L.P. | Bronchodilating compositions and methods |
DE10141376A1 (de) | 2001-08-23 | 2003-03-13 | Boehringer Ingelheim Pharma | Verfahren zur Herstellung von Inhalationspulvern |
GB0125127D0 (en) | 2001-10-19 | 2001-12-12 | Glaxo Group Ltd | Compounds |
DE10205087A1 (de) | 2002-02-07 | 2003-08-21 | Pharmatech Gmbh | Cyclodextrine als Suspensionsstabilisatoren in druckverflüssigten Treibmitteln |
US7244742B2 (en) | 2002-08-17 | 2007-07-17 | Boehringer Ingelheim Pharma Gmbh & Co Kg | Pharmaceutical compositions for inhalation containing an anticholinergic, corticosteroid and betamimetic |
US20040241103A1 (en) | 2002-09-10 | 2004-12-02 | 3M Innovative Properties Company | Pharmaceutical aerosol compositions |
US7550133B2 (en) | 2002-11-26 | 2009-06-23 | Alexza Pharmaceuticals, Inc. | Respiratory drug condensation aerosols and methods of making and using them |
CN1197579C (zh) | 2003-01-14 | 2005-04-20 | 鲁南制药股份有限公司 | 治疗支气管哮喘的组合物 |
EP1452179A1 (en) * | 2003-02-27 | 2004-09-01 | CHIESI FARMACEUTICI S.p.A. | Novel medicament combination of a highly potent long-lasting beta2-agonist and a corticosteroid |
US7459146B2 (en) | 2003-05-30 | 2008-12-02 | 3M Innovative Properties Company | Stabilized aerosol dispersions |
US7109247B2 (en) | 2003-05-30 | 2006-09-19 | 3M Innovative Properties Company | Stabilized particle dispersions containing nanoparticles |
US7487345B2 (en) | 2003-10-10 | 2009-02-03 | Dell Products L.P. | Method of comparing build capability flags of replacement BIOS with boot capability flags of current BIOS to determine compatibility between BIOS revisions and installed hardware during flash update |
US20070020299A1 (en) * | 2003-12-31 | 2007-01-25 | Pipkin James D | Inhalant formulation containing sulfoalkyl ether cyclodextrin and corticosteroid |
DE102004048389A1 (de) | 2004-10-01 | 2006-04-06 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Modifizierung von Oberflächen von Laktose als Hilfsstoff zur Verwendung für Pulverinhalativa |
DE102004048390A1 (de) | 2004-10-01 | 2006-04-06 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Neue Pulverinhalativa auf Basis modifizierter Laktosemischungen als Hilfsstoff |
ZA200704378B (en) | 2004-12-17 | 2008-07-30 | Cipla Ltd | Pharmaceutical compounds and compositions |
US7694676B2 (en) | 2005-04-22 | 2010-04-13 | Boehringer Ingelheim Gmbh | Dry powder inhaler |
DE102006009599A1 (de) | 2005-10-28 | 2007-05-03 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Treibgasabsorbtion bei Dosieraerosolen mit Verpackungen |
EP1971369B1 (en) | 2005-12-21 | 2009-08-19 | MEDA Pharma GmbH & Co. KG | Combination of r,r-glycopyrrolate, rolipram and budesonide for the treatment of inflammatory diseases |
GB0614621D0 (en) * | 2006-07-24 | 2006-08-30 | 3M Innovative Properties Co | Metered dose dispensers |
US20080078382A1 (en) | 2006-09-20 | 2008-04-03 | Lemahieu Edward | Methods and Systems of Delivering Medication Via Inhalation |
US20080066739A1 (en) | 2006-09-20 | 2008-03-20 | Lemahieu Edward | Methods and systems of delivering medication via inhalation |
US20090047336A1 (en) | 2007-08-17 | 2009-02-19 | Hong Kong Baptist University | novel formulation of dehydrated lipid vesicles for controlled release of active pharmaceutical ingredient via inhalation |
US20090263495A1 (en) | 2007-10-25 | 2009-10-22 | Revalesio Corporation | Bacteriostatic or bacteriocidal compositions and methods |
US20100008997A1 (en) | 2007-10-25 | 2010-01-14 | Revalesio Corporation | Compositions and methods for treating asthma and other lung disorders |
CN101433527A (zh) | 2007-11-13 | 2009-05-20 | 天津金耀集团有限公司 | 植物胶囊在粉雾剂中的应用 |
-
2010
- 2010-09-28 CN CN201010502339.3A patent/CN102416179B/zh active Active
-
2011
- 2011-02-01 US US13/876,387 patent/US8877740B2/en not_active Expired - Fee Related
- 2011-02-01 KR KR1020137010636A patent/KR101475262B1/ko active IP Right Grant
- 2011-02-01 AU AU2011307899A patent/AU2011307899B2/en not_active Ceased
- 2011-02-01 NZ NZ607900A patent/NZ607900A/en not_active IP Right Cessation
- 2011-02-01 SG SG2013016621A patent/SG188426A1/en unknown
- 2011-02-01 EP EP11827927.2A patent/EP2626065A4/en not_active Withdrawn
- 2011-02-01 WO PCT/CN2011/070883 patent/WO2012041031A1/zh active Application Filing
- 2011-02-01 MY MYPI2013000680A patent/MY179794A/en unknown
- 2011-02-01 CA CA2811345A patent/CA2811345C/en not_active Expired - Fee Related
-
2012
- 2012-10-16 HK HK12110225.2A patent/HK1169334A1/zh not_active IP Right Cessation
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1305380A (zh) * | 1998-06-11 | 2001-07-25 | 阿斯特拉曾尼卡有限公司 | 含有福莫特罗和布地奈德的组合物在预防和治疗急性气喘疾病中的应用 |
CN1298699A (zh) * | 2000-02-15 | 2001-06-13 | 丛繁滋 | 速效平喘气雾剂及其制备方法 |
CN1353980A (zh) * | 2001-11-14 | 2002-06-19 | 丛繁滋 | 速效平喘气雾剂及其制备方法 |
Also Published As
Publication number | Publication date |
---|---|
HK1169334A1 (zh) | 2013-01-25 |
WO2012041031A1 (zh) | 2012-04-05 |
CA2811345C (en) | 2015-08-11 |
US8877740B2 (en) | 2014-11-04 |
KR20140032936A (ko) | 2014-03-17 |
NZ607900A (en) | 2014-08-29 |
CN102416179A (zh) | 2012-04-18 |
AU2011307899B2 (en) | 2015-03-12 |
SG188426A1 (en) | 2013-04-30 |
EP2626065A1 (en) | 2013-08-14 |
MY179794A (en) | 2020-11-14 |
KR101475262B1 (ko) | 2014-12-22 |
EP2626065A4 (en) | 2014-03-12 |
AU2011307899A1 (en) | 2013-04-04 |
CA2811345A1 (en) | 2012-04-05 |
US20140031324A1 (en) | 2014-01-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102416179B (zh) | 用于哮喘的吸入性复方组合物 | |
Barnes | The properties of inhaled corticosteroids: similarities and differences | |
AU2002347948B2 (en) | Albuterol inhalation solution, system, kit and method for relieving symptoms of pediatric asthma | |
JPH08504438A (ja) | 医薬活性化合物を投与するための系 | |
Bateman et al. | Comparison of twice-daily inhaled ciclesonide and fluticasone propionate in patients with moderate-to-severe persistent asthma | |
TW202142232A (zh) | 用於治療、改善或預防冠狀病毒感染之製品與方法 | |
JP2016519160A (ja) | 3つ以上の活性薬剤を呼吸性送達するための組成物、方法、及びシステム | |
CN107998109A (zh) | 药物组合物 | |
ZA200502177B (en) | Inhalation composition | |
IL167009A (en) | Dry powder formoterol or its derivatives for inhalation | |
JP2010540607A (ja) | セチリジンと、非β2−アドレナリン受容体作動薬、β2−アドレナリン受容体作動薬、又は抗炎症薬とを含む組成物及びそれらの呼吸器疾患治療への使用法 | |
TW200524615A (en) | Aqueous suspensions of ciclesonide for nebulisation | |
CN101657191B (zh) | 包括福莫特罗和二丙酸倍氯米松的组合物在制备用于预防和/或治疗哮喘恶化的药物中的用途 | |
CN103476412B (zh) | 用于改善呼吸系统疾病患者睡眠质量的阿地铵 | |
WO2000053187A1 (en) | New combination of formoterol and mometasone in a pharmaceutical composition for treating respiratory disorders, such as asthma, rhinitis and copd | |
AU2002334126B2 (en) | Pharmaceutical combinations comprising salmeterol and fluticasone proprionate for the treatment of asthma | |
Hsieh et al. | Comparative efficacy and tolerability of beclomethasone/formoterol and fluticasone/salmeterol fixed combination in Taiwanese asthmatic patients | |
CN105209013A (zh) | 喷雾干燥制剂经喷雾混合的脱非晶化 | |
CN112839633A (zh) | 包含药剂的低共熔溶剂及其制造方法和用途 | |
TWI495466B (zh) | 用於氣喘之吸入性複方組合物 | |
CN107106516A (zh) | 药物组合产品 | |
Thamby et al. | Retrospective studies on drug utilization patterns of asthmatics in a Government hospital in Kedah, Malaysia | |
CN101842102A (zh) | Dheas吸入组合物 | |
JP2014528458A (ja) | 鼻炎の治療 | |
Van Schoor | Focus on Innuvair® inhaler for asthma |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
ASS | Succession or assignment of patent right |
Owner name: YIDE BIOTECHNOLOGY CO., LTD. Free format text: FORMER OWNER: JIANQIAO XINYUAN MEIDICNE BIOTECHNOLOGY CO., LTD. Effective date: 20120802 |
|
C41 | Transfer of patent application or patent right or utility model | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20120802 Address after: Taiwan Taipei City Lake Road China section of No. 392 11 floor Applicant after: Yide Biological Technology Co., Ltd. Address before: Taiwan Taipei City Lake Road China section of No. 396 11 floor Applicant before: Synmosa Biopharma Corp. |
|
REG | Reference to a national code |
Ref country code: HK Ref legal event code: DE Ref document number: 1169334 Country of ref document: HK |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
REG | Reference to a national code |
Ref country code: HK Ref legal event code: GR Ref document number: 1169334 Country of ref document: HK |